Takehiro Suzuki
Molecular Biology · 2011–2017
A researcher in the Science corpus: 10 papers; trusts 21 researchers and is trusted by 4 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 145 citations into it; #7,616 of 17,773 by trust here, #6,095 by citations
- Surgery — 9 citations into it
Whom Takehiro Suzuki trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Ryuji Hamamoto
- Hyun-soo Cho
- S. Hayami
- G. Toyokawa
- Masanori Yoshimatsu
- Lianhua Piao
- Yusuke Nakamura
- Yoichi Furukawa
- John D. Kelly
- Makoto Nakakido
Who trusts Takehiro Suzuki overall
Papers from Takehiro Suzuki's perspective
Ordered by how strongly the researchers Takehiro Suzuki trusts endorse each paper. Same corpus, a different order for every researcher.
- SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells
- Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers
- Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. (Cell)
- p53 is regulated by the lysine demethylase LSD1 (Nature)
- A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5′ flanking region of SMYD3 is a risk factor for human cancers
- Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers
- Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker
- Polycomb silencers control cell fate, development and cancer (Nature Reviews. Cancer)
- Epigenetic modifications and human disease (Nature Biotechnology)
- LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription (Nature)
Their papers
- Abstract 3019: Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells (2011) — 207 citations
- SUV39H2 methylates and stabilizes LSD1 by inhibiting polyubiquitination in human cancer cells (2015) — 50 citations
- RB1 methylation by SMYD2 enhances cell cycle progression through an increase of RB1 phosphorylation. (2012) — 196 citations
- The histone methyltransferase SMYD2 methylates PARP1 and promotes poly(ADP-ribosyl)ation activity in cancer cells. (2014) — 104 citations
- PRMT1 promotes mitosis of cancer cells through arginine methylation of INCENP (2015) — 36 citations
- Dysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN (2015) — 92 citations
- Critical roles of SMYD2-mediated β-catenin methylation for nuclear translocation and activation of Wnt signaling (2017) — 43 citations
- Protein lysine methyltransferase SMYD3 is involved in tumorigenesis through regulation of HER2 homodimerization (2017) — 31 citations
- SMYD3-mediated lysine methylation in the PH domain is critical for activation of AKT1 (2016) — 51 citations
- PRMT6 increases cytoplasmic localization of p21CDKN1A in cancer cells through arginine methylation and makes more resistant to cytotoxic agents (2015) — 50 citations